Guinea starts testing Merck vaccine in Ebola hotspots

March 25, 2015 3:01 PM

14 0

CONAKRY/DAKAR (Reuters) - Guinea started testing an experimental Ebola vaccine from Merck and NewLink Genetics on affected communities this week, in a move officials hope will accelerate the end of an epidemic first detected a year ago.

But some worry about violent reactions from communities fearful about healthcare workers' intentions in a country where resistance to the anti-Ebola campaign has been strongest.

Read more

To category page